The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Risk Factors for Visual Field Progression in Treated Glaucoma
Abstract
OBJECTIVE: To determine intraocular pressure (IOP)-dependent and IOP-independent variables associated with visual field (VF) progression in treated glaucoma. DESIGN: Retrospective cohort of the Glaucoma Progression Study. METHODS: Consecutive, treated glaucoma patients with repeatable VF loss who had 8 or more VF examinations of either eye, using the Swedish Interactive Threshold Algorithm (24-2 SITA-Standard, Humphrey Field Analyzer II; Carl Zeiss Meditec, Inc, Dublin, California), during the period between January 1999 and September 2009 were included. Visual field progression was evaluated using automated pointwise linear regression. Evaluated data included age, sex, race, central corneal thickness, baseline VF mean deviation, mean follow-up IOP, peak IOP, IOP fluctuation, a detected disc hemorrhage, and presence of beta-zone parapapillary atrophy. RESULTS: We selected 587 eyes of 587 patients (mean [SD] age, 64.9 [13.0] years). The mean (SD) number of VFs was 11.1 (3.0), spanning a mean (SD) of 6.4 (1.7) years. In the univariable model, older age (odds ratio [OR], 1.19 per decade; P = .01), baseline diagnosis of exfoliation syndrome (OR, 1.79; P = .01), decreased central corneal thickness (OR, 1.38 per 40 μm thinner; P < .01), a detected disc hemorrhage (OR, 2.31; P < .01), presence of beta-zone parapapillary atrophy (OR, 2.17; P < .01), and all IOP parameters (mean follow-up, peak, and fluctuation; P < .01) were associated with increased risk of VF progression. In the multivariable model, peak IOP (OR, 1.13; P < .01), thinner central corneal thickness (OR, 1.45 per 40 μm thinner; P < .01), a detected disc hemorrhage (OR, 2.59; P < .01), and presence of beta-zone parapapillary atrophy (OR, 2.38; P < .01) were associated with VF progression. CONCLUSIONS: IOP-dependent and IOP-independent risk factors affect disease progression in treated glaucoma. Peak IOP is a better predictor of progression than is IOP mean or fluctuation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Capps, L. (2003) · JAMA · doi:10.1001/jama.290.18.2487-b · Cited by 4,526
(2000) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(00)00538-9 · Cited by 2,780
Gordon, M. O. (2002) · Archives of Ophthalmology · doi:10.1001/archopht.120.6.714 · Cited by 2,626
Causes and Prevalence of Visual Impairment Among Adults in the UnitedStates
(2004) · Archives of Ophthalmology · doi:10.1001/archopht.122.4.477 · Cited by 2,616
Tunis (2003) · doi:10.1001/jama.290.12.1624 · Cited by 1,724
Predictors of Long-term Progression in the Early Manifest Glaucoma Trial
Leske, M. C., Heijl, A., Hyman, L., Bengtsson, B., Dong, L., & Yang, Z. (2007) · Ophthalmology · doi:10.1016/j.ophtha.2007.03.016 · Cited by 1,363
Asrani, S., Zeimer, R., Wilensky, J., Gieser, D., Vitale, S., & Lindenmuth, K. (2000) · Journal of Glaucoma · doi:10.1097/00061198-200004000-00002 · Cited by 901
Racial Variations in the Prevalence of Primary Open-angle Glaucoma: The Baltimore Eye Survey
Tielsch, J. M. (1991) · JAMA · doi:10.1001/jama.1991.03470030069026 · Cited by 879
Risk factors for progression of visual field abnormalities in normal-tension glaucoma
Drance, S., Anderson, D. R., & Schulzer, M. (2001) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(01)00964-3 · Cited by 790
Racial Differences in the Cause-Specific Prevalence of Blindness in East Baltimore
Sommer, A., Tielsch, J. M., Katz, J., Quigley, H. A., Gottsch, J. D., Javitt, J. C., Martone, J. F., Royall, R. M., Witt, K. A., & Ezrine, S. (1991) · New England Journal of Medicine · doi:10.1056/nejm199111143252004 · Cited by 764
Nouri-Mahdavi, K., Hoffman, D., Coleman, A. L., Liu, G., Li, G., Gaasterland, D., & Caprioli, J. (2004) · Ophthalmology · doi:10.1016/j.ophtha.2004.02.017 · Cited by 704
Practical recommendations for measuring rates of visual field change in glaucoma
Chauhan, B. C., Garway-Heath, D. F., Goni, F. J., Rossetti, L., Bengtsson, B., Viswanathan, A. C., & Heijl, A. (2008) · British Journal of Ophthalmology · doi:10.1136/bjo.2007.135012 · Cited by 530
Fluctuation of Intraocular Pressure and Glaucoma Progression in the Early Manifest Glaucoma Trial
Bengtsson, B., Leske, M. C., Hyman, L., & Heijl, A. (2007) · Ophthalmology · doi:10.1016/j.ophtha.2006.07.060 · Cited by 454
Visual Field Progression in the Collaborative Initial Glaucoma Treatment Study
Musch, D. C., Gillespie, B. W., Lichter, P. R., Niziol, L. M., & Janz, N. K. (2009) · Ophthalmology · doi:10.1016/j.ophtha.2008.08.051 · Cited by 439
Glasgow, R. E., Magid, D. J., Beck, A., Ritzwoller, D., & Estabrooks, P. A. (2005) · Medical Care · doi:10.1097/01.mlr.0000163645.41407.09 · Cited by 308
Risk Factors for the Development of Glaucomatous Visual Field Loss in Ocular Hypertension
Quigley, H. A. (1994) · Archives of Ophthalmology · doi:10.1001/archopht.1994.01090170088028 · Cited by 304
Parapapillary chorioretinal atrophy in normal and glaucoma eyes. I. Morphometric data.
Jonas, J. B., Nguyen, X. N., Gusek, G. C., & Naumann, G. O. H. (1989) · PubMed · Cited by 296
Budenz, D. L., Anderson, D. R., Feuer, W. J., Beiser, J. A., Schiffman, J., Parrish, R. K., Piltz-Seymour, J. R., Gordon, M. O., & Kass, M. A. (2006) · Ophthalmology · doi:10.1016/j.ophtha.2006.06.022 · Cited by 283
Wells, A. P., Garway-Heath, D. F., Poostchi, A., Wong, T., Chan, K. C. Y., & Sachdev, N. (2008) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.07-1556 · Cited by 265
Medeiros, F. A., Sample, P. A., Zangwill, L. M., Bowd, C., Aihara, M., & Weinreb, R. N. (2003) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(03)00484-7 · Cited by 248
Burgoyne, C. F., & Downs, J. C. (2008) · Journal of Glaucoma · doi:10.1097/ijg.0b013e31815a343b · Cited by 214
Scleral Biomechanics in the Aging Monkey Eye
Girard, M. J. A., Suh, J.-K. F., Bottlang, M., Burgoyne, C. F., & Downs, J. C. (2009) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.08-3363 · Cited by 208
Madison, T., Schottenfeld, D., James, S. A., Schwartz, A. G., & Gruber, S. B. (2004) · American Journal of Public Health · doi:10.2105/ajph.94.12.2104 · Cited by 189
Prediction of Functional Loss in Glaucoma From Progressive Optic Disc Damage
(2009) · Archives of Ophthalmology · doi:10.1001/archophthalmol.2009.276 · Cited by 188
Stage and delay in breast cancer diagnosis by race, socioeconomic status, age and year
Richardson, J., Langholz, B., Bernstein, L., Burciaga, C., Danley, K., & Ross, R. (1992) · British Journal of Cancer · doi:10.1038/bjc.1992.193 · Cited by 188
Medeiros, F. A., Weinreb, R. N., Zangwill, L. M., Alencar, L. M., Sample, P. A., Vasile, C., & Bowd, C. (2008) · Ophthalmology · doi:10.1016/j.ophtha.2007.08.012 · Cited by 172
Miglior, S., Torri, V., Zeyen, T., Pfeiffer, N., Vaz, J. C., & Adamsons, I. (2007) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2007.04.040 · Cited by 172
Parapapillary chorioretinal atrophy in normal and glaucoma eyes. II. Correlations.
Jonas, J. B., & Naumann, G. O. H. (1989) · PubMed · Cited by 168
Epstein, D. L., Krug, J. H., Hertzmark, E., Remis, L. L., & Edelstein, D. J. (1989) · Ophthalmology · doi:10.1016/s0161-6420(89)32688-1 · Cited by 163
Race and Primary Open-Angle Glaucoma
Martin, M. J., Summer, A., Gold, E. B., & Diamond, E. L. (1985) · American Journal of Ophthalmology · doi:10.1016/0002-9394(85)90001-7 · Cited by 161
Increasing peripapillary atrophy is associated with progressive glaucoma
Uchida, H., Uğurlu, Ş., & Caprioli, J. (1998) · Ophthalmology · doi:10.1016/s0161-6420(98)98044-7 · Cited by 159
Association between Intraocular Pressure Peaks and Progression of Visual Field Loss
Zeimer, R. C., Wilensky, J. T., Gieser, D. K., & Viana, M. A. G. (1991) · Ophthalmology · doi:10.1016/s0161-6420(91)32340-6 · Cited by 159
Gardiner, S. K., & Crabb, D. P. (2002) · PubMed · Cited by 153
Peripapillary chorioretinal atrophy
Curcio, C. A., Saunders, P. L., Younger, P. W., & Malek, G. (2000) · Ophthalmology · doi:10.1016/s0161-6420(99)00037-8 · Cited by 138
Race as a risk factor for progressive glaucomatous damage.
Wilson, R. P., Richardson, T. M., Hertzmark, E., & Grant, W. M. (1985) · PubMed · Cited by 112
Jonas, J. B., Martus, P., Horn, F. K., Ju¨nemann, A., Korth, M., & Budde, W. M. (2004) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.03-1274 · Cited by 107
Ischaemic optic neuropathy in chronic simple glaucoma.
Begg, I. S., Drance, S. M., & Sweeney, V. P. (1971) · British Journal of Ophthalmology · doi:10.1136/bjo.55.2.73 · Cited by 101
Visual Field Progression Differences between Normal-Tension and Exfoliative High-Tension Glaucoma
Ahrlich, K., Moraes, C. G. V. D., Teng, C. C., Prata, T. S., Tello, C. A., Ritch, R. H., & Liebmann, J. M. (2010) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.09-3806 · Cited by 99
Chauhan, B. C., Nicolela, M. T., & Artes, P. H. (2009) · Ophthalmology · doi:10.1016/j.ophtha.2009.04.031 · Cited by 98
Wormald, R., Basauri, E., Wright, L. A., & Evans, J. (1994) · Eye · doi:10.1038/eye.1994.64 · Cited by 97
Misconceptions about Breast Lumps and Delayed Medical Presentation in Urban Breast Cancer Patients
Rauscher, G. H., Ferrans, C. E., Kaiser, K., Campbell, R. T., Calhoun, E., & Warnecke, R. B. (2010) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-09-0997 · Cited by 93
Brown, M. M. (2005) · Evidence-Based Eye Care · doi:10.1097/01.ieb.0000150377.43306.1d · Cited by 70
Predictors of and Barriers Associated With Poor Follow-up in Patients With Glaucoma in South India
Lee, B. W. (2008) · Archives of Ophthalmology · doi:10.1001/archopht.126.10.1448 · Cited by 70
Against pragmatism: on efficacy, effectiveness and the real world
Kent, D. M., & Kitsios, G. D. (2009) · Trials · doi:10.1186/1745-6215-10-48 · Cited by 52
The management of exfoliative glaucoma
Ritch, R. H. (2008) · Progress in brain research · doi:10.1016/s0079-6123(08)01115-1 · Cited by 46
Shimmyo, M. (2004) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2004.01.041 · Cited by 44
Optic disk characteristics before the occurrence of disk hemorrhage in glaucoma patients
Law, S. K., Choe, R., & Caprioli, J. (2001) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(01)01009-1 · Cited by 42
Do effectiveness (“real world”) studies on antipsychotics tell us the real truth?
Möller, H. (2008) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-008-0812-0 · Cited by 39
Wei, J. T. (2006) · Yearbook of Urology · doi:10.1016/s0084-4071(08)70206-9 · Cited by 33
Kass, M. A. (1989) · Europe PMC (PubMed Central) · Cited by 29
A Comparison of Treated and Untreated Glaucoma Suspects
Drance, S. M., Douglas, G. R., & Schulzer, M. (1991) · Springer eBooks · doi:10.1007/978-3-642-76084-6_25 · Cited by 13
Myers, J. S. (2009) · Yearbook of Ophthalmology · doi:10.1016/s0084-392x(09)79126-9 · Cited by 10
Cited by
Optical Coherence Tomography Angiography of Optic Disc Perfusion in Glaucoma
Jia, Y., Wei, E., Wang, X., Zhang, X., Morrison, J. C., Parikh, M., Lombardi, L. H., Gattey, D. M., Armour, R. L., Edmunds, B., et al. (2014) · Ophthalmology · doi:10.1016/j.ophtha.2014.01.021 · Cited by 740
Primary Open-Angle Glaucoma Preferred Practice Pattern®
Gedde, S. J., Vinod, K., Wright, M. M., Muir, K. W., Lind, J. T., Chen, P. P., Li, T., & Mansberger, S. L. (2021) · Ophthalmology · doi:10.1016/j.ophtha.2020.10.022 · Cited by 474
Normal tension glaucoma: review of current understanding and mechanisms of the pathogenesis
Killer, H., & Pircher, A. (2018) · Eye · doi:10.1038/s41433-018-0042-2 · Cited by 262
Metadata
- Authors
- De Moraes, C. G. V.
- Venue
- Archives of Ophthalmology
- Publisher
- American Medical Association (AMA)
- Published
- 2010-05-12
- Volume
- 129
- Issue
- 5
- Pages
- 562
- ISSN
- 0003-9950 (ISSN-L)
- OpenAlex
- W1965921725
- Cited by
- 356
- References
- 52
- FWCI
- 16.81
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.